BOSTON (AP) — A Massachusetts drug company with the same founders as a compounding pharmacy tied to a deadly meningitis outbreak has agreed with state regulators to remain closed through the year.

Ameridose first agreed to close for inspection in October after tainted steroids from its sister company, the New England Compounding Center, were linked to a fungal meningitis outbreak that caused 32 deaths. The agreement has been extended several times. The latest would have expired Monday.